Therapeutic developments in metabolic dysfunction-associated fatty liver disease

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become one of the most prevalent chronic liver diseases worldwide, bringing risk of multiorgan disfunctions including cardiovascular events, complications of cirrhosis, and even malignance. In terms of health burden management, screeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yiwen, Fan, Jiangao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276260/
https://www.ncbi.nlm.nih.gov/pubmed/35234696
http://dx.doi.org/10.1097/CM9.0000000000002091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276260/
https://www.ncbi.nlm.nih.gov/pubmed/35234696
http://dx.doi.org/10.1097/CM9.0000000000002091

Ejemplares similares